Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009 Jul;6(7):405-18.
doi: 10.1038/nrclinonc.2009.72. Epub 2009 Jun 2.

Molecular and Cellular Mechanisms of CLL: Novel Therapeutic Approaches

Affiliations
Review

Molecular and Cellular Mechanisms of CLL: Novel Therapeutic Approaches

Lisa Pleyer et al. Nat Rev Clin Oncol. .

Abstract

The mainstay of therapy of chronic lymphocytic leukemia (CLL) is cytotoxic chemotherapy; however, CLL is still an incurable disease with resistance to therapy developing in the majority of patients. In recent years, our understanding of the biological basis of CLL pathogenesis has substantially improved and novel treatment strategies are emerging. Tailoring and individualizing therapy according to the molecular and cellular biology of the disease is on the horizon, and advances with targeted agents such as monoclonal antibodies combined with traditional chemotherapy have lead to improved remission rates. The proposed key role of the B-cell receptor (BCR) in CLL pathogenesis has led to a number of possible opportunities for therapeutic exploitation. We are beginning to understand that the microenvironment is of utmost importance in CLL because certain T-cell subsets and stromal cells support the outgrowth and development of the malignant clone. Furthermore, an increase in our understanding of the deregulated cell-death machinery in CLL is a prerequisite to developing new targeted strategies that might be more effective in engaging with the cell-death machinery. This Review summarizes the progress made in understanding these features of CLL biology and describes novel treatment strategies that have also been exploited in current clinical trials.

Similar articles

See all similar articles

Cited by 55 articles

See all "Cited by" articles

References

    1. Blood. 2007 Jun 15;109(12):5390-8 - PubMed
    1. J Immunol. 1997 Feb 1;158(3):1482-9 - PubMed
    1. Annu Rev Genet. 2005;39:23-46 - PubMed
    1. J Biol Chem. 2006 Jan 13;281(2):813-23 - PubMed
    1. Blood. 2005 Mar 15;105(6):2436-42 - PubMed

Publication types

MeSH terms

LinkOut - more resources

Feedback